409 related articles for article (PubMed ID: 29327101)
21. Nanoparticle-mediated delivery of therapeutic genes: focus on miRNA therapeutics.
Muthiah M; Park IK; Cho CS
Expert Opin Drug Deliv; 2013 Sep; 10(9):1259-73. PubMed ID: 23826971
[TBL] [Abstract][Full Text] [Related]
22. Nanoparticle/siRNA-based therapy strategies in glioma: which nanoparticles, which siRNAs?
Aigner A; Kögel D
Nanomedicine (Lond); 2018 Jan; 13(1):89-103. PubMed ID: 29199893
[TBL] [Abstract][Full Text] [Related]
23. Nanoparticle-based delivery system for application of siRNA in vivo.
Wang Y; Li Z; Han Y; Liang LH; Ji A
Curr Drug Metab; 2010 Feb; 11(2):182-96. PubMed ID: 20359287
[TBL] [Abstract][Full Text] [Related]
24. RNAi Therapeutic Platforms for Lung Diseases.
Fujita Y; Takeshita F; Kuwano K; Ochiya T
Pharmaceuticals (Basel); 2013 Feb; 6(2):223-50. PubMed ID: 24275949
[TBL] [Abstract][Full Text] [Related]
25. Direct cytoplasmic delivery of RNAi therapeutics through a non-lysosomal pathway for enhanced gene therapy.
Zhou J; Zhang J; Chen S; Lin Q; Zhu R; Wang L; Chen X; Li J; Yang H
Acta Biomater; 2023 Oct; 170():401-414. PubMed ID: 37625679
[TBL] [Abstract][Full Text] [Related]
26. Functional nanostructures for effective delivery of small interfering RNA therapeutics.
Hong CA; Nam YS
Theranostics; 2014; 4(12):1211-32. PubMed ID: 25285170
[TBL] [Abstract][Full Text] [Related]
27. Tumor-targeted RNA-interference: functional non-viral nanovectors.
Pan X; Thompson R; Meng X; Wu D; Xu L
Am J Cancer Res; 2011 Sep; 1(1):25-42. PubMed ID: 21572539
[TBL] [Abstract][Full Text] [Related]
28. Polymer-based delivery of RNA-based therapeutics in ovarian cancer.
Weirauch U; Gutsch D; Höbel S; Aigner A
Methods Mol Biol; 2013; 1049():443-65. PubMed ID: 23913237
[TBL] [Abstract][Full Text] [Related]
29. In vivo application of RNA interference: from functional genomics to therapeutics.
Lu PY; Xie F; Woodle MC
Adv Genet; 2005; 54():117-42. PubMed ID: 16096010
[TBL] [Abstract][Full Text] [Related]
30. Delivery of small interfering RNAs by nanovesicles for cancer therapy.
Pengnam S; Plianwong S; Yingyongnarongkul BE; Patrojanasophon P; Opanasopit P
Drug Metab Pharmacokinet; 2022 Feb; 42():100425. PubMed ID: 34954489
[TBL] [Abstract][Full Text] [Related]
31. Chemical and structural modifications of RNAi therapeutics.
Ku SH; Jo SD; Lee YK; Kim K; Kim SH
Adv Drug Deliv Rev; 2016 Sep; 104():16-28. PubMed ID: 26549145
[TBL] [Abstract][Full Text] [Related]
32. Prospects for the potential of RNA interference in the treatment of autoimmune diseases: Small interfering RNAs in the spotlight.
Gorabi AM; Kiaie N; Aslani S; Jamialahmadi T; Johnston TP; Sahebkar A
J Autoimmun; 2020 Nov; 114():102529. PubMed ID: 32782117
[TBL] [Abstract][Full Text] [Related]
33. Nanoparticle-based delivery of small interfering RNA: challenges for cancer therapy.
Miele E; Spinelli GP; Miele E; Di Fabrizio E; Ferretti E; Tomao S; Gulino A
Int J Nanomedicine; 2012; 7():3637-57. PubMed ID: 22915840
[TBL] [Abstract][Full Text] [Related]
34. Environment-Responsive Lipid/siRNA Nanoparticles for Cancer Therapy.
Lu ZR; Laney VEA; Hall R; Ayat N
Adv Healthc Mater; 2021 Mar; 10(5):e2001294. PubMed ID: 33615743
[TBL] [Abstract][Full Text] [Related]
35. Nanoparticles for siRNA-Based Gene Silencing in Tumor Therapy.
Babu A; Muralidharan R; Amreddy N; Mehta M; Munshi A; Ramesh R
IEEE Trans Nanobioscience; 2016 Dec; 15(8):849-863. PubMed ID: 28092499
[TBL] [Abstract][Full Text] [Related]
36. RNA interference (RNAi)-based plasmonic nanomaterials for cancer diagnosis and therapy.
Yoon J; Shin M; Lee JY; Lee SN; Choi JH; Choi JW
J Control Release; 2022 Feb; 342():228-240. PubMed ID: 35016917
[TBL] [Abstract][Full Text] [Related]
37. Tumor-targeting multifunctional nanoparticles for siRNA delivery: recent advances in cancer therapy.
Ku SH; Kim K; Choi K; Kim SH; Kwon IC
Adv Healthc Mater; 2014 Aug; 3(8):1182-93. PubMed ID: 24577795
[TBL] [Abstract][Full Text] [Related]
38. Polyethylenimines for RNAi-mediated gene targeting in vivo and siRNA delivery to the lung.
Günther M; Lipka J; Malek A; Gutsch D; Kreyling W; Aigner A
Eur J Pharm Biopharm; 2011 Apr; 77(3):438-49. PubMed ID: 21093588
[TBL] [Abstract][Full Text] [Related]
39. Clinical Applications of Short Non-Coding RNA-Based Therapies in the Era of Precision Medicine.
Smith ES; Whitty E; Yoo B; Moore A; Sempere LF; Medarova Z
Cancers (Basel); 2022 Mar; 14(6):. PubMed ID: 35326738
[TBL] [Abstract][Full Text] [Related]
40. Lipid nanoparticles for short interfering RNA delivery.
Leung AK; Tam YY; Cullis PR
Adv Genet; 2014; 88():71-110. PubMed ID: 25409604
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
